title: Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the metabolism of LHRH and TRH in brain.
abstract: Intraneuronal peptide regulatory mechanisms are still poorly understood. The cytosolic enzymes prolyl endopeptidase (EC 3.4.21.26) and pyroglutamyl peptidase I (E.C.3.4.19.3) degrade both TRH and LHRH. Previous studies from this laboratory have not supported a role for these enzymes in the control of TRH levels. These studies have now been extended to cell and organ cultures and examine the effects of enzyme inhibition on LHRH. Exposure of dispersed hypothalamic cells or median eminences in culture to Z-Pro-Prolinal and pyroglutamyl diazomethyl ketone, specific inhibitors of prolyl endopeptidase and pyroglutamyl peptidase I respectively, did not change TRH content or recovery of released TRH. In vivo and in vitro treatment with these inhibitors did not modify the content of LHRH or recovery of this peptide upon release from several brain regions except in the olfactory bulb where an unexpected decrease in levels was observed. Olfactory bulb levels of TRH also decreased but only after prolonged in vivo inhibitor treatment. The decrease in olfactory bulb LHRH and TRH could not be accounted for by enzyme induction and is likely due to a non-specific or indirect effect of the inhibitors on the processing of these peptides. These studies demonstrate that levels of LHRH and TRH in brain are not controlled by cytosolic peptidases.
authors.affiliation: Departamento de Bioquimica de Proteinas, Universidad Nacional Autonoma de Mexico, Cuernavaca Mor.
authors.forename: M
authors.initials: M
authors.lastname: Mendez
authors.forename: C
authors.initials: C
authors.lastname: Cruz
authors.forename: P
authors.initials: P
authors.lastname: Joseph-Bravo
authors.forename: S
authors.initials: S
authors.lastname: Wilk
authors.forename: J L
authors.initials: JL
authors.lastname: Charli
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002478:Cells, Cultured; D004151:Dipeptides / Q000494:pharmacology; D004622:Embryo, Mammalian; D010450:Endopeptidases / Q000378:metabolism*; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008473:Median Eminence / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D009830:Olfactory Bulb / Q000187:drug effects / Q000378:metabolism; D009924:Organ Culture Techniques; D000085822:Prolyl Oligopeptidases; D011751:Pyroglutamyl-Peptidase I / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012697:Serine Endopeptidases; D013973:Thyrotropin-Releasing Hormone / Q000378:metabolism*
chemical_list: D004151:Dipeptides; D007987:Gonadotropin-Releasing Hormone; D013973:Thyrotropin-Releasing Hormone; C038541:N-benzyloxycarbonylprolylprolinal; C046251:pyroglutamyl diazomethyl ketone; D010450:Endopeptidases; D011751:Pyroglutamyl-Peptidase I; D012697:Serine Endopeptidases; D000085822:Prolyl Oligopeptidases; D011761:Pyrrolidonecarboxylic Acid